Formosa Plastics stock
1301.TWTAIFormosa Plastics Corporation, Basic MaterialsISIN TW0001301000
41Score 41 out of 100, Weak
Price and trend
67 / 100
Price history
+65% in one yearThe chart shows daily closes over 20 years, adjusted for stock splits and without dividends. Click into the chart to set a price alert at that price.
Above the 200-day line: the price is 22% above it.
Since August 2025 the 50-day line has been above the 200-day line; the trend has turned up.
Normal: the price is neither overheated nor sold off (RSI 39).
The price is 23% below its 52-week high. Largest decline in 20 years: 73% (October 2021 to January 2025).
Chart figures for advanced users
- SMA 50$2.13
- Average price of the last 50 trading days, shows the short-term trend.
- SMA 200$1.70
- Average price of the last 200 trading days, shows the long-term trend.
- RSI (14)39
- Relative strength over the last 14 days on a scale from 0 to 100. Above 70 the price counts as overheated, below 30 as sharply fallen.
- MACDbelow the signal line
- Compares a fast and a slow price average. Above its signal line momentum is rising, below it momentum is fading.
- Support$1.12
- The lowest closing price of the last twelve months.
- Resistance$2.71
- The highest closing price of the last twelve months.
Snapshot
Computed from the data by fixed rules, no AI
- Formosa Plastics Corporation belongs to the Chemicals (Specialty) industry (Taiwan) and, with a market value of $13.24B, is number 24 of 106 companies in its industry on MEQIRI.
- In fiscal 2025 it reported revenue of $5.34B (down 12.3% year on year) and a loss of $305.9M.
- For fiscal 2026, analysts expect on average revenue of $5.52B (up 3.5%) and adjusted earnings per share of $0.12.
Show more
- MEQIRI Score 41 out of 100 (Weak): rank 381 of 461 in Basic Materials, median 57.
- The P/E is 41.5 (Chemicals (Specialty) median 22.5, own median of recent years 14.8).
- Our model puts fair value at $1.76, with the price 18% above it.
In plain words
The numbers on this page in plain words, written by an AI
Strengths
- More cash than debtCash $8.35B, financial debt $4.87B.Stability 57
- Analysts expect strong earnings growthUp 16.7% a year through 2028 (estimates from 4 analysts).
Weaknesses
- Margin fallingOperating margin −4.3%, average of the prior years 13.7% (to 2024).Profitability 25
- Turned to a lossEarnings per share from $0.10 in 2020 to −$0.05.Growth 12
- Richly valuedP/E 41.5, Chemicals (Specialty) median 22.5, own median 14.8.Valuation 33
Its standout strength is momentum, while profitability and growth hold the score back.
Daily figure as of 13 Nov 2026
How the score is calculatedScore overview
Score since yesterday from 42 to 41.
Fundamental quality fluctuates.
Score history
The full history of up to 20 years comes with MEQIRI Pro.
See plansCrash risk not measured
How well MEQIRI warnsFor stocks from Japan, China, Hong Kong, Taiwan, Korea, Canada, India and Brazil we only show crash risk once a separate backtest shows that it warns as well there as in the US and Europe.
Valuation
Valuation signal
Fairly valuedIn our model the price counts as cheap below $1.26 and expensive above $2.94 (uncertainty high, based on the price swings of the past year).
The two parts of the fair value come to $2.40 (cash-flow model) and $1.13 (industry comparison), and the gap between them shows how uncertain the estimate is.
Calculated with a cost of equity of 9.2%. At 10.2% the fair value would be $1.57, at 8.2% it would be $2.04.
Valuation metrics
Half from the cash-flow model, half from earnings times the industry P/E (22.5).
Calculate with your own assumptionsCompany performance
This shows several years of history with an automatic assessment.
Revenue
In the twelve months to 30 Jun 2026, revenue fell 11% on the twelve months before. Revenue has stayed largely stable since 2006.
Margins
- Gross margin
- Operating margin
- Net margin
In fiscal 2025: gross 3%, operating −4%, net −6%. Last 12 months: net 6%.
Debt & balance sheet
latest quarterDebt is low, but interest coverage is weak. Keep an eye on the interest burden and refinancing.
Earnings
- Next earnings
- 12 Jan 2027in 60 days
- Last reported
- 12 Aug 2026EPS reported $0.05 (expected $0.02)above expectations
Analyst estimates
Earnings estimates have barely changed since 23 Oct 2026.
- Earnings per share
- $0.120.0%
- Revenue
- $5.52B0.0%
- Earnings per share
- $0.110.0%
- Revenue
- $5.55B0.0%
MEQIRI has stored the estimates since 23 Oct 2026. Until 30 days are available, the card shows the change since that day. Mean estimate according to Financial Modeling Prep. No price target and no recommendation.
What happened at Formosa Plastics
The key events of the last six months from our own data. A click takes you to the matching card.
Sector comparison
461 rated companies in Basic Materials
- This company
- 41
- Sector median
- 57
Categories against the sector median
The median is the middle value: half of the companies in the sector lie above it, half below. Categories with too few comparable companies are left out.
Competitors in Chemicals (Specialty)
The next larger and next smaller companies by market value
- Sociedad Química y Minera de ChileSQM $15.39B71
- SymriseSY1.DE $14.74B60
- Nitto Denko6988.T $14.05B75
- Covestro1COV.DE $13.9B43
- RPM InternationalRPM $13.15B67
- Swancor Advanced Materials688585.SS $12.88B49
- Akzo NobelAKZA.AS $12.07B63
- Satellite Chemical002648.SZ $11.72B71
ETFs that hold Formosa Plastics
Held by 40 ETFs on Xetra. Shown per index: the ETF with the largest weight.
| ETF | Weight | Cost | Fund size |
|---|---|---|---|
| Xtrackers MSCI Taiwan UCITS ETF 1CDBX5 | 0.40% | 0.65% | €558.25M |
| Invesco RAFI Emerging Markets Fundamental Value UCITS ETF6PSK | 0.31% | 0.49% | €86.78M |
| Franklin FTSE Asia ex China ex Japan UCITS ETFFVSJ | 0.10% | 0.14% | €547.95M |
Show 5 more
| HSBC MSCI AC FAR EAST ex JAPAN UCITS ETF USDH411 | 0.09% | 0.45% | €400.6M |
| iShares MSCI EM Asia UCITS ETFCEBL | 0.09% | 0.20% | €7.14B |
| Vanguard FTSE Emerging Markets UCITS ETF (USD) AccumulatingVFEA | 0.08% | 0.17% | €5.24B |
| Avantis Emerging Markets Equity UCITS ETF USD AccAVEM | 0.08% | 0.35% | €284.54M |
| State Street SPDR MSCI Emerging Markets UCITS ETFSPYM | 0.08% | 0.18% | €1.92B |
Holdings as reported by the funds via FMP, excluding swap ETFs (their holdings are only collateral).
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Currency
- Amounts in US dollars, converted at the ECB reference rate of 12 Nov 2026 ($1 = NT$32.8500)
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Weak, published since 7 Nov 2026 (in the score history since 30 Sep 2023)
- Valuation signal Fairly valued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.